Search Results for 'hiv nrti'

hiv nrti published presentations and documents on DocSlides.

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
by maximus
DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
by roxanne
FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
Optimizing HIV treatment
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...
Management of NRTI Resistance
Management of NRTI Resistance
by giovanna-bartolotta
David Spach, MD. Principal . Investigator, NW AET...
Comparison of NNRTI vs PI/r
Comparison of NNRTI vs PI/r
by alexa-scheidler
EFV vs LPV/r vs EFV + LPV/r . A5142. Mexican. . ...
Advances and Challenges in HIV Antiretroviral Therapy
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
CROI 2019:  ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Dolutegravir ( Tivicay )
Dolutegravir ( Tivicay )
by brown
Prepared by:. Brian R. Wood, MD. David H. Spach, M...
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
by taylor
Supported by an educational grant from Gilead Scie...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
ART in Women and  Contraception: InSTIs
ART in Women and Contraception: InSTIs
by olivia-moreira
ART in Women and Contraception: InSTIs , Comorbi...
Ellen G. Chadwick, MD Professor of Pediatrics
Ellen G. Chadwick, MD Professor of Pediatrics
by mitsue-stanley
Northwestern University Feinberg School of Medici...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Switch to DRV/r
Switch to DRV/r
by mitsue-stanley
monotherapy. MONOI. MONET. PROTEA. DRV600. Design...
HIV Drug Resistance in Well-Resourced Settings
HIV Drug Resistance in Well-Resourced Settings
by faustina-dinatale
Vincent Marconi, . MD. Outline. Transmitted Drug ...
Comparison of NRTI combinations
Comparison of NRTI combinations
by tawny-fly
ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
by luanne-stotts
Chief, Division of Infectious Diseases. Weill Med...
Modifying Therapy in the Treatment-experienced Patient:
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Meg  Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Dolutegravir   vs.  Raltegravir
Dolutegravir vs. Raltegravir
by zoe
SPRING-2 Study. Dolutegravir. versus Raltegravir....
Switch PI/R to ETR Etraswitch
Switch PI/R to ETR Etraswitch
by dustin869
Etraswitch. . Study. : Switch PI/r to ETR. Contin...